STOCK TITAN

[SCHEDULE 13G] Longeveron Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Longeveron Inc. reporting persons Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC disclose shared beneficial ownership equal to 2,143,418 shares of Class A common stock, representing approximately 9.99% of the class as of August 15, 2025. The holdings are issuable upon exercise of Intracoastal Warrant 1 and are subject to blocker provisions that limit exercise to prevent exceeding specified ownership thresholds (9.99% or 4.99% depending on the warrant). The filing specifies no sole voting or dispositive power and that the positions are not held to change or influence control of the issuer.

Positive

  • None.

Negative

  • None.

Insights

TL;DR Reporting persons hold a near-10% diluted stake via warrants with blocker provisions, a meaningful disclosure but not an immediate control change.

The Schedule 13G shows shared beneficial ownership of 2,143,418 shares (9.99%) attributable to Intracoastal Warrant 1 and related issuance. The absence of sole voting or dispositive power indicates coordinated, not unilateral, influence. Blocker provisions restrict exercise to remain below set thresholds, limiting near-term dilution and control shifts. For investors, this clarifies potential future dilution sources and governance exposure tied to warrant exercise mechanics.

TL;DR The filing confirms a coordinated position below the 10% reporting threshold with formal blocker limits, reducing immediate governance risk.

The document discloses shared voting and dispositive power only, and certification that the securities were not acquired to change control. The blocker provisions embedded in multiple warrants are central: they legally prevent exercise that would push ownership past 9.99% or 4.99%, which mitigates sudden governance shifts. This is important for board and shareholder oversight considerations.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Mitchell P. Kopin
Signature:/s/ Mitchell P. Kopin
Name/Title:Mitchell P. Kopin
Date:08/15/2025
Daniel B. Asher
Signature:/s/ Daniel B. Asher
Name/Title:Daniel B. Asher
Date:08/15/2025
Intracoastal Capital LLC
Signature:/s/ Mitchell P. Kopin
Name/Title:Mitchell P. Kopin, Manager
Date:08/15/2025
Exhibit Information

Exhibit 1 - Joint Filing Agreement

Longeveron Inc

NASDAQ:LGVN

LGVN Rankings

LGVN Latest News

LGVN Latest SEC Filings

LGVN Stock Data

11.94M
16.90M
14.83%
6.96%
5.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
MIAMI